159 related articles for article (PubMed ID: 31646560)
1. LncRNA CASC15 promotes migration and invasion in prostate cancer via targeting miR-200a-3p.
Zhang C; Wang GX; Fu B; Zhou XC; Li Y; Li YY
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8303-8309. PubMed ID: 31646560
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA CASC15 is upregulated in glioma and facilitates cell proliferation and metastasis via targeting miR-130b-3p.
Xie Y; Cheng Y
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7475-7481. PubMed ID: 31539135
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA CASC15 is upregulated in non-small cell lung cancer and facilitates cell proliferation and metastasis via targeting miR-130b-3p.
Yu DJ; Zhong M; Wang WL
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7943-7949. PubMed ID: 31599419
[TBL] [Abstract][Full Text] [Related]
4. LncRNA CASC15 functions as an oncogene by sponging miR-130b-3p in bladder cancer.
Yu X; Wang ZL; Han CL; Wang MW; Jin Y; Jin XB; Xia QH
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9814-9820. PubMed ID: 31799648
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA CASC15 promotes nasopharyngeal carcinoma cell proliferation and metastasis by downregulating miR-101-3p.
Xue MY; Cao HX
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8897-8904. PubMed ID: 31696476
[TBL] [Abstract][Full Text] [Related]
6. LncRNA SNHG16 functions as an oncogene by sponging miR-200a-3p in pancreatic cancer.
Guo JQ; Yang ZJ; Wang S; Wu ZZ; Yin LL; Wang DC
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1718-1724. PubMed ID: 32141539
[TBL] [Abstract][Full Text] [Related]
7. LncRNA PROX1-AS1 promotes proliferation, invasion, and migration in prostate cancer via targeting miR-647.
Qian C; Liao CH; Tan BF; Chen YF; Dang BW; Chen JL; Liu CB
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):2938-2944. PubMed ID: 32271411
[TBL] [Abstract][Full Text] [Related]
8. LncRNA CASC15 is Upregulated in Osteosarcoma Plasma Exosomes and CASC15 Knockdown Inhibits Osteosarcoma Progression by Regulating miR-338-3p/RAB14 Axis.
Zhang H; Wang J; Ren T; Huang Y; Yu Y; Chen C; Huang Q; Guo W
Onco Targets Ther; 2020; 13():12055-12066. PubMed ID: 33262606
[TBL] [Abstract][Full Text] [Related]
9. LncRNA MALAT1 contributes to non-small cell lung cancer progression via modulating miR-200a-3p/programmed death-ligand 1 axis.
Wei S; Wang K; Huang X; Zhao Z; Zhao Z
Int J Immunopathol Pharmacol; 2019; 33():2058738419859699. PubMed ID: 31240979
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA SNHG16 acts as an oncogene in Wilms' tumor through sponging miR-200a-3p.
Zhao XS; Tao N; Zhang C; Gong CM; Dong CY
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4145-4151. PubMed ID: 32373950
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA SNHG14 promotes breast cancer cell proliferation and invasion via sponging miR-193a-3p.
Xie SD; Qin C; Jin LD; Wang QC; Shen J; Zhou JC; Chen YX; Huang AH; Zhao WH; Wang LB
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2461-2468. PubMed ID: 30964172
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA CASC15 promotes proliferation and induces apoptosis of cervical cancer cells through targeting miR-101-3p.
Zhang YN; Liu B; Jiang T; Li Q
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):611-618. PubMed ID: 32016962
[TBL] [Abstract][Full Text] [Related]
13. miR-200a-3p facilitates bladder cancer cell proliferation by targeting the
Wan P; Chen Z; Huang M; Jiang H; Wu H; Zhong K; Ding G; Wang B
Transl Androl Urol; 2021 Nov; 10(11):4262-4274. PubMed ID: 34984191
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA MALAT1 knockdown inhibits progression of anaplastic thyroid carcinoma by regulating miR-200a-3p/FOXA1.
Gou L; Zou H; Li B
Cancer Biol Ther; 2019; 20(11):1355-1365. PubMed ID: 31500506
[TBL] [Abstract][Full Text] [Related]
15. LncRNA INHBA-AS1 promotes cell growth, migration, and invasion of oral squamous cell carcinoma by sponging miR-143-3p.
Ma WQ; Chen J; Fang W; Yang XQ; Zhu A; Zhang D; Zhong HL; Yang B; Luo Z
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1821-1828. PubMed ID: 32141551
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of TUG1/miRNA-299-3p Axis Represses Pancreatic Cancer Malignant Progression via Suppression of the Notch1 Pathway.
Xu K; Zhang L
Dig Dis Sci; 2020 Jun; 65(6):1748-1760. PubMed ID: 31655908
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA SNHG10 upregulates BIN1 to suppress the tumorigenesis and epithelial-mesenchymal transition of epithelial ovarian cancer via sponging miR-200a-3p.
Lv W; Jia Y; Wang J; Duan Y; Wang X; Liu T; Hao S; Liu L
Cell Death Discov; 2022 Feb; 8(1):60. PubMed ID: 35149697
[TBL] [Abstract][Full Text] [Related]
18. CASC15 contributes to proliferation and invasion through regulating miR-766-5p/ KLK12 axis in lung cancer.
Bai Y; Zhang G; Cheng R; Yang R; Chu H
Cell Cycle; 2019 Sep; 18(18):2323-2331. PubMed ID: 31378128
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA HOXA-AS2 acts as an oncogene by targeting miR-145-3p in human non-small cell lung cancer.
Shi YB; Liu SL; Mou XR; Liao J; Che JP; Fei XQ; Wang AR
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1243-1249. PubMed ID: 32096154
[TBL] [Abstract][Full Text] [Related]
20. LncRNA cancer susceptibility candidate 15 accelerates the breast cancer cells progression via miR-153-3p/KLF5 positive feedback loop.
Yu L; Xu Q; Yu W; Duan J; Dai G
Biochem Biophys Res Commun; 2018 Dec; 506(4):819-825. PubMed ID: 30389133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
